In obesity, both IGF1 concentrations and vitamin D status are reduced [19,20]; yet, for both variables, associations have been seen between lower concentrations and high blood pressure, disturbed glucose metabolism, cardiovascular disease, and adverse lipid profiles, regardless of body mass [21]. This evidence concerns the gene IGF1 and obesity due to melanocortin 4 receptor deficiency.